SH Department of Neurology – John Hopkins University Related Content
A new wave of molecular cancer therapeutics
Hernando Lopez-Bertoni, explores the new wave of molecular cancer therapeutics and states the case for learning the mechanisms as a pro, so one can target them as an artist.
miRNAs in brain cancer therapy – Mighty things from small beginnings grow
Dr Hernando Lopez-Bertoni at the Department of Neurology, Johns Hopkins School of medicine, discusses the development of miRNAs in brain cancer therapy
miRNA-based therapeutics to treat Glioblastoma at Johns Hopkins Medical Institute in Baltimore
Dr. Hernando Lopez-Bertoni discusses the development of innovative molecular therapeutics using miRNAs to treat high-grade brain tumours.
